The connexin 36 blockers quinine, quinidine and mefloquine inhibit cortical spreading depression in a rat neocortical slice model in vitro

Brain Research Bulletin

Volumn 71, Issue 1-3, 2006, Pages 23-28

  Margineanu, Doru Georg ^a   Klitgaard, Henrik ^a  

^a UCB PHARMA   (Belgium)

Author keywords

Connexin 36; Gap junctions; Migraine aura; MK 801

Indexed keywords

ANIMALS; CELL COMMUNICATION; CONNEXINS; DOSE-RESPONSE RELATIONSHIP, DRUG; GAP JUNCTIONS; MALE; MEFLOQUINE; MEMBRANE POTENTIALS; MODELS, NEUROLOGICAL; NEOCORTEX; ORGAN CULTURE TECHNIQUES; POTASSIUM CHANNEL BLOCKERS; QUINIDINE; QUININE; RATS; RATS, SPRAGUE-DAWLEY; SPREADING CORTICAL DEPRESSION;

EID: 33750986822     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2006.07.011     Document Type: Article

References (32)

1. Anderson T.R., and Andrew R.D. Spreading depression: imaging and blockade in the rat neocortical brain slice. J. Neurophysiol. 88 (2002) 2713-2725
2. Back T., Ginsberg M.D., Dietrich W.D., and Watson B.D. Induction of spreading depression in the ischemic hemisphere following experimental middle cerebral artery occlusion: effect on infarct morphology. J. Cereb. Blood Flow Metab. 16 (1996) 202-213
3. Belluardo N., Mudo G., Trovato-Salinaro A., Le Gurun S., Charollais A., Serre-Beinier V., Amato G., Haefliger J.-A., Meda P., and Condorelli D.F. Expression of Connexin36 in the adult and developing rat brain. Brain Res. 865 (2000) 121-138
4. Bikson M., Id Bihi R., Vreugdenhil M., Köhling R., Fox J.E., and Jefferys J.G.R. Quinine suppresses extracellular potassium transients and ictal epileptiform activity without decreasing neuronal excitability in vitro. Neuroscience 115 (2002) 251-261
5. Bureš J., Burešová O., and Huston J. Techniques and Basic Experiments for the Study of Brain and Behavior (1976), Elsevier, Amsterdam pp 188-195
6. Clement E.M., Grahame-Smith D.G., and Elliott J.M. Investigation of the presynaptic effects of quinine and quinidine on the release and uptake of monoamines in rat brain tissue. Neuropharmacol 37 (1998) 945-951
7. Cruikshank S.J., Hopperstad M., Younger M., Connors B.W., Spray D.C., and Srinivas M. Potent block of Cx36 and Cx50 gap junction channels by mefloquine. Proc. Natl. Acad. Sci. USA 101 (2004) 12364-12369
8. Gajda Z., Szupera Z., Blazso G., and Szente M. Quinine, a blocker of neuronal Cx36 channels, suppresses seizure activity in rat neocortex in vivo. Epilepsia 46 (2005) 1581-1591
9. Gorji A. Spreading depression: a review of the clinical relevance. Brain Res. Rev. 38 (2001) 33-60
10. Gorji A., Scheller D., Straub H., Tegtmeier F., Köhling R., Höhling J.-M., Tuxhorn I., Ebner A., Wolf P., Panneck H.W., Oppel F., and Speckmann E.-J. Spreading depression in human neocortical slices. Brain Res. 906 (2001) 74-83
11. Hadjikhani N., Sanchez del Rio M., Wu O., Schwartz D., Bakker D., Fischl B., Kwong K.K., Cutrer F.M., Rosen B.R., Tootell R.B., Sorensen A.G., and Moskowitz M.A. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc. Natl. Acad. Sci. USA 98 (2001) 4687-4692
12. Iadecola C. From CSD to headache: a long and winding road. Nature Med. 8 (2002) 110-112
13. Imai S., Suzuki T., Sato K., and Tokimasa T. Effects of quinine on three different types of potassium currents in bullfrog sympathetic neurons. Neurosci. Lett. 275 (1999) 121-124
14. Kager H., Wadman W.J., and Somjen G.G. Simulated seizures and spreading depression in a neuron model incorporating interstitial space and ion concentrations. J. Neurophysiol. 84 (2000) 495-512
15. Largo C.L., Tombaugh G.C., Aitken P.G., Herreras O., and Somjen G.G. Heptanol but not fluoroacetate prevents the propagation of rat spreading depression in rat hippocampal slices. J. Neurophysiol. 77 (1997) 9-16
16. Lashley K.S. Patterns of cerebral integration indicated by the scotomas of migraine. Arch. Neurol. Psychiatry 46 (1941) 331-339
17. Lauritzen M. Pathophysiology of the migraine aura. The spreading depression theory. Brain 117 (1994) 199-210
18. Leão A.A.P. Spreading depression of activity in the cerebral cortex. J. Neurophysiol. 7 (1944) 359-390
19. Margineanu D.G., and Klitgaard H. Can gap-junction blockade preferentially inhibit neuronal hypersynchrony vs. excitability?. Neuropharmacology 41 (2001) 377-383
20. Milner P.M. Note on a possible correspondence between the scotomas of migraine and spreading depression of Leão. EEG Clin. Neurophysiol. 10 (1958) 705
21. Martins-Ferreira H., Nedergaard M., and Nicholson C. Perspectives on spreading depression. Brain Res. Rev. 32 (2000) 215-234
22. Nagy J.I., Dudek F.E., and Rash J.E. Update on connexins and gap junctions in neurons and glia in the mammalian nervous system. Brain Res. Rev. 47 (2004) 191-215
23. Nedergaard M., Cooper A.J.L., and Goldman S.A. Gap junctions are required for the propagation of spreading depression. J. Neurobiol. 28 (1995) 433-444
24. 2+ waves and spreading depression in the mouse neocortex. J. Neurosci. 23 (2003) 9888-9896
25. Pietrobon D., and Striessnig J. Neurobiology of migraine. Nature Rev. Neurosci. 4 (2003) 386-398
26. Rouach N., Segal M., Koulakoff A., Giaume C., and Avignone E. Carbenoxolone blockade of neuronal network activity in culture is not mediated by an action on gap junctions. J. Physiol. 553 3 (2003) 729-745
27. Somjen G.G. Mechanisms of spreading depression and hypoxic spreading depression-like depolarization. Physiol. Rev. 81 (2001) 1065-1095
28. Srinivas M., Hopperstad M.G., and Spray D.C. Quinine blocks specific gap junction channel subtypes. Proc. Natl. Acad. Sci. USA 98 (2001) 10942-10947
29. 2+ signaling. J. Neurosci. 26 (2006) 1378-1385
30. J.W. Tracy, L.T. Webster, Drugs used in the chemotherapy of protozoal infections Malaria, J.G. Hardman, L.E. Limbird (Editors-in-Chief), Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th ed., McGraw-Hill, New York, 1996, pp. 965-985.
31. A antagonists. Neuropharmacology 43 (2002) 563-572
32. Világi I., Klapka N., and Kuhmann H.J. Optical recording of spreading depression in rat neocortical slices. Brain Res. 898 (2001) 288-296